EP Patent

EP0518468A1 — Melatonin containing compositions

Assigned to Neurim Pharmaceuticals 1991 Ltd · Expires 1992-12-16 · 33y expired

What this patent protects

A pharmaceutical controlled-release formulation comprises melatonin in combination with at least one pharmaceutical carrier, diluent or coating, and is adapted to release melatonin over a predetermined time period, according to a profile which, taking into account the existing pr…

USPTO Abstract

A pharmaceutical controlled-release formulation comprises melatonin in combination with at least one pharmaceutical carrier, diluent or coating, and is adapted to release melatonin over a predetermined time period, according to a profile which, taking into account the existing profile, simulates the profile in plasma of a human having a normal endogenous melatonin profile. The invention further relates to use in the manufacture of a medicament for therapeutic application in the the prevention of sudden infant death syndrome in infants, of a formulation which comprises melatonin in combination with at least one diluent, carrier, coating or adjuvant.

Drugs covered by this patent

Patent Metadata

Patent number
EP0518468A1
Jurisdiction
EP
Classification
—
Expires
1992-12-16
Drug substance claim
No
Drug product claim
No
Assignee
Neurim Pharmaceuticals 1991 Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.